Conversely, the reduction in Snail1, Vimentin and MMP-9 expression as well as the increase in E-cadherin expression in the MCF-7-liposome-si-CD147 group indicate that targeting CD147 could potentially reverse EMT in breast cancer cells. This evidence concerns the gene VIM and breast cancer.